Liver enzyme elevation in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: a single-center historical cohort study
Su Jin Choi, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim
Korean J Intern Med. 2020;35(3):723-731. Published online 2019 Dec 26 DOI: https://doi.org/10.3904/kjim.2018.407
Citations to this article as recorded by 
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review
Joanna Leaviss, Christopher Carroll, Munira Essat, Danielle van der Windt, Matthew J Grainge, Tim Card, Richard Riley, Abhishek Abhishek
RMD Open.2024; 10(1): e003588. CrossRef
Primary Biliary Cholangitis with Ankylosing Spondylitis
Young Mi Hong, Ki Tae Yoon, Mong Cho
The Korean Journal of Gastroenterology.2022; 79(6): 270. CrossRef
Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
Soo-Young Na, You Sun Kim
The Korean Journal of Internal Medicine.2022; 37(5): 906. CrossRef
Dynamics of Cytokine Profile Indicators Changes in Animals with Acute Generalized Peritonitis on the Background of Diabetes Mellitus
Ihor Yakovych Dzubanovsky, Svilana Romanivna Pidruchna, Natalia Anatoliivna Melnyk, Serhiy Mykhailovych Andreychyn, Bogdana Mykhailivna Vervega, Natalia Anatoliina Nychyk
Journal of Medicine and Life.2020; 13(3): 404. CrossRef